Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Liu

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Nuclear Medicine|August 1, 2025
On the construction of a large-scale database of AI-assisted annotating lung ventilation-perfusion scintigraphy for pulmonary embolism (VQ4PEDB)Amir Jabbarpour, Eric Moulton, Sanaz Kaviani, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|September 15, 2022
Age-Related Modifications of Muscle Synergies and Their Temporal Activations for Overground WalkingXiaoyu Guo, Borong He, Kelvin Y S Lau, et al.
Circulation. Genomic and Precision Medicine|April 10, 2025
Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials BiorepositoryMatthew Muller, Richard Liu, Farheen Shah, et al.
The American Journal of Cardiology|June 6, 2024
Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA TrialsCarine E Hamo, Richard Liu, Wenbo Wu, et al.
Pediatrics|July 8, 2020
Body Mass Index From Early to Late Childhood and Cardiometabolic Measurements at 11 to 12 YearsKate Lycett, Markus Juonala, Costan G Magnussen, et al.
Circulation|November 9, 2005
Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodelingHaili Su, Francis G Spinale, Lawrence W Dobrucki, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
The discovery of BMS-457, a potent and selective CCR1 antagonistDaniel S Gardner, Joseph B Santella, John V Duncia, et al.
Journal of Medicinal Chemistry|March 1, 2016
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based SeriesScott H Watterson, Junqing Guo, Steve H Spergel, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2016
Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1)Junqing Guo, Scott H Watterson, Steven H Spergel, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritisJoseph B Santella, Daniel S Gardner, John V Duncia, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Nuclear Medicine|August 1, 2025
On the construction of a large-scale database of AI-assisted annotating lung ventilation-perfusion scintigraphy for pulmonary embolism (VQ4PEDB)Amir Jabbarpour, Eric Moulton, Sanaz Kaviani, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|September 15, 2022
Age-Related Modifications of Muscle Synergies and Their Temporal Activations for Overground WalkingXiaoyu Guo, Borong He, Kelvin Y S Lau, et al.
Circulation. Genomic and Precision Medicine|April 10, 2025
Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials BiorepositoryMatthew Muller, Richard Liu, Farheen Shah, et al.
The American Journal of Cardiology|June 6, 2024
Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA TrialsCarine E Hamo, Richard Liu, Wenbo Wu, et al.
Pediatrics|July 8, 2020
Body Mass Index From Early to Late Childhood and Cardiometabolic Measurements at 11 to 12 YearsKate Lycett, Markus Juonala, Costan G Magnussen, et al.
Circulation|November 9, 2005
Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodelingHaili Su, Francis G Spinale, Lawrence W Dobrucki, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
The discovery of BMS-457, a potent and selective CCR1 antagonistDaniel S Gardner, Joseph B Santella, John V Duncia, et al.
Journal of Medicinal Chemistry|March 1, 2016
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based SeriesScott H Watterson, Junqing Guo, Steve H Spergel, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2016
Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1)Junqing Guo, Scott H Watterson, Steven H Spergel, et al.
Journal of Medicinal Chemistry|August 8, 2014
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritisJoseph B Santella, Daniel S Gardner, John V Duncia, et al.
Pageof 10